GR80364B - Solutions of lactic salts of piperazinylchinolon-and piperazinyl-azachinolon carbon acids - Google Patents

Solutions of lactic salts of piperazinylchinolon-and piperazinyl-azachinolon carbon acids

Info

Publication number
GR80364B
GR80364B GR80364A GR840180364A GR80364B GR 80364 B GR80364 B GR 80364B GR 80364 A GR80364 A GR 80364A GR 840180364 A GR840180364 A GR 840180364A GR 80364 B GR80364 B GR 80364B
Authority
GR
Greece
Prior art keywords
piperazinylchinolon
azachinolon
piperazinyl
solutions
carbon acids
Prior art date
Application number
GR80364A
Other languages
Greek (el)
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6209428&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR80364(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of GR80364B publication Critical patent/GR80364B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR80364A 1983-09-17 1984-09-14 Solutions of lactic salts of piperazinylchinolon-and piperazinyl-azachinolon carbon acids GR80364B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833333719 DE3333719A1 (de) 1983-09-17 1983-09-17 Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren

Publications (1)

Publication Number Publication Date
GR80364B true GR80364B (en) 1985-01-14

Family

ID=6209428

Family Applications (1)

Application Number Title Priority Date Filing Date
GR80364A GR80364B (en) 1983-09-17 1984-09-14 Solutions of lactic salts of piperazinylchinolon-and piperazinyl-azachinolon carbon acids

Country Status (24)

Country Link
US (3) US4705789A (cg-RX-API-DMAC10.html)
EP (1) EP0138018B1 (cg-RX-API-DMAC10.html)
JP (1) JPS6094910A (cg-RX-API-DMAC10.html)
KR (1) KR870001958B1 (cg-RX-API-DMAC10.html)
AU (1) AU562507B2 (cg-RX-API-DMAC10.html)
CA (1) CA1228547A (cg-RX-API-DMAC10.html)
DD (1) DD227882A5 (cg-RX-API-DMAC10.html)
DE (2) DE3333719A1 (cg-RX-API-DMAC10.html)
DK (1) DK162811C (cg-RX-API-DMAC10.html)
ES (1) ES8607021A1 (cg-RX-API-DMAC10.html)
FI (1) FI83286C (cg-RX-API-DMAC10.html)
GR (1) GR80364B (cg-RX-API-DMAC10.html)
HK (1) HK74789A (cg-RX-API-DMAC10.html)
HU (1) HU194733B (cg-RX-API-DMAC10.html)
IE (1) IE57905B1 (cg-RX-API-DMAC10.html)
IL (1) IL72953A (cg-RX-API-DMAC10.html)
NO (1) NO171765C (cg-RX-API-DMAC10.html)
NZ (1) NZ209548A (cg-RX-API-DMAC10.html)
PL (1) PL144897B1 (cg-RX-API-DMAC10.html)
PT (1) PT79206B (cg-RX-API-DMAC10.html)
SG (1) SG21489G (cg-RX-API-DMAC10.html)
SU (1) SU1384187A3 (cg-RX-API-DMAC10.html)
UA (1) UA8025A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA847267B (cg-RX-API-DMAC10.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3608745A1 (de) * 1985-07-24 1987-01-29 Bayer Ag Bakterizide zubereitungen zur anwendung auf dem gebiet der veterinaermedizin
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
JPH0696533B2 (ja) * 1987-01-14 1994-11-30 北陸製薬株式会社 キノロンカルボン酸の水性組成物
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
US5225413A (en) * 1988-09-16 1993-07-06 Bayer-Aktiengesellschaft pH-neutral aqueous solutions of quinolone-carboxylic acids
NZ232091A (en) * 1989-01-16 1990-12-21 Bellon Labor Sa Roger 7-fluoro-8-(piperazin-1-yl)-4-oxo-1,4-dihydro-benzo(b)(1,8)naphthyridine-3-carboxylic acid derivatives, preparation and pharmaceutical compositions thereof
DK0507851T3 (da) * 1989-12-29 1997-08-25 Abbott Lab Quinoloncarboxylsyre-matalion-syrekomplekser
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
TW254855B (cg-RX-API-DMAC10.html) * 1993-07-28 1995-08-21 Otsuka Pharma Co Ltd
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
KR960000223A (ko) * 1994-06-08 1996-01-25 김정순 신규한 피리돈 카르복실산 화합물을 함유한 수용액 및 이의 제조방법
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
IN186245B (cg-RX-API-DMAC10.html) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6306856B1 (en) 1998-09-18 2001-10-23 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid, solubilizer therefor, aqueous solution preparation containing pyridonecarboxylic acid and process for producing the same
DE102004005186B3 (de) * 2004-02-02 2005-10-13 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von gereinigtem Ciprofloxacin
DE102004054873A1 (de) * 2004-11-12 2006-05-18 Bayer Healthcare Ag Behandlung von Mastitis
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
AU2005313601B2 (en) * 2004-12-09 2012-05-24 Bayer Intellectual Property Gmbh Stabilisation of glucocorticoid esters with acids
BRPI1010981A2 (pt) 2009-05-15 2018-12-04 Redx Pharma Ltd "derivados de fármaco redox"
CN103479569A (zh) * 2013-01-14 2014-01-01 四川喜亚动物药业有限公司 兽用环丙沙星注射液及其制备方法
US10034690B2 (en) 2014-12-09 2018-07-31 John A. Heflin Spine alignment system

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE296839C (cg-RX-API-DMAC10.html) *
CH296839A (de) * 1944-03-14 1954-02-28 Knoll Ag Verfahren zur Herstellung von haltbaren, wässrigen Lösungen von Salzen von Strychninoxyd.
DE2047486A1 (de) * 1970-09-26 1972-03-30 Merck Patent Gmbh, 6100 Darmstadt Verfahren zur Stabilisierung einer pynthioxinhaltigen, wässerigen Injektions lösung
US4022894A (en) * 1975-03-03 1977-05-10 Fainberg Samuel M Stable solution of benzthiazide (3-[benzythiol methyl]-6-chloro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide) suitable for parenteral administration and process of preparation
JPS6019910B2 (ja) * 1979-10-11 1985-05-18 大塚製薬株式会社 ベンゾ〔ij〕キノリジン−2−カルボン酸誘導体及びその製造法
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
JPS5531028A (en) * 1978-08-25 1980-03-05 Dai Ichi Seiyaku Co Ltd Injection
DE2918319A1 (de) * 1979-05-07 1980-11-13 Roehm Pharma Gmbh Therapeutische verabreichungsform
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
JPS57188515A (en) * 1981-05-13 1982-11-19 Kyoto Yakuhin Kogyo Kk Stabilized aqueous dopamine preparation
HU188181B (en) * 1981-06-11 1986-03-28 Warner-Lambert Co,Us Process for producing salts of naphtiridine and quinoline compounds of antimicrobial activity

Also Published As

Publication number Publication date
EP0138018A2 (de) 1985-04-24
PL249591A1 (en) 1987-03-09
US4705789A (en) 1987-11-10
AU562507B2 (en) 1987-06-11
NZ209548A (en) 1987-02-20
HU194733B (en) 1988-03-28
IL72953A (en) 1988-01-31
SU1384187A3 (ru) 1988-03-23
HK74789A (en) 1989-09-22
KR870001958B1 (ko) 1987-10-23
ZA847267B (en) 1985-05-29
DE3333719A1 (de) 1985-04-04
DE3474915D1 (en) 1988-12-08
DK441084D0 (da) 1984-09-14
HUT35513A (en) 1985-07-29
US4808585A (en) 1989-02-28
SG21489G (en) 1989-09-22
NO843518L (no) 1985-03-18
AU3297684A (en) 1985-03-21
FI843587L (fi) 1985-03-18
IE842347L (en) 1985-03-17
DD227882A5 (de) 1985-10-02
PL144897B1 (en) 1988-07-30
CA1228547A (en) 1987-10-27
JPS6094910A (ja) 1985-05-28
JPH0559893B2 (cg-RX-API-DMAC10.html) 1993-09-01
ES535832A0 (es) 1986-05-16
US4808583A (en) 1989-02-28
NO171765C (no) 1993-05-05
ES8607021A1 (es) 1986-05-16
DK441084A (da) 1985-03-18
IL72953A0 (en) 1984-12-31
EP0138018B1 (de) 1988-11-02
IE57905B1 (en) 1993-05-05
FI83286C (fi) 1991-06-25
PT79206A (en) 1984-10-01
NO171765B (no) 1993-01-25
PT79206B (en) 1986-08-14
DK162811B (da) 1991-12-16
FI843587A0 (fi) 1984-09-13
UA8025A1 (uk) 1995-12-26
DK162811C (da) 1992-05-04
EP0138018A3 (en) 1986-10-08
KR850002096A (ko) 1985-05-06
FI83286B (fi) 1991-03-15

Similar Documents

Publication Publication Date Title
ZA847267B (en) Solutions of lactic acid salts of piperazinyl-quinolone-and piperazinyl-azaquinolone-carboxylic acids
DE3475520D1 (en) Metal salts of lower dialkylphosphorodithioic acids
GB8425097D0 (en) Aminocarboxylic acid salts
HUT35641A (en) Process for preparing 1-benzyl-amino-alkyl-pirrolidinones and acid addition salts thereof
DE3470415D1 (en) Acid salts of valproic acid
DE3262438D1 (en) Process for the preparation of alpha-aryl-propionic acids and their alkaline salts
AU564919B2 (en) 5-thioxo-2-imidazolinyl benzioc acids, esters, salts and related compounds
DE3465188D1 (en) Acid salts of valproic acid
DE3660912D1 (en) Process for the preparation of acyloxybenzenesulphonic acids and their salts
DE3462139D1 (en) Process for the preparation of hydroxybenzylphosphonium salts
GB2181158B (en) Electrolytic process for the manufacture of salts
DE3460618D1 (en) Process for the preparation of fluorocarboxylic acids
YU218284A (en) Process for making carbon salts
KE3875A (en) Solutions of lactic acid salts of piperazinylquinolone and piperazinyl-azaquinolinecarboxylic acids
PL252375A1 (en) Method of obtaining novel substituted isochomates and oxepins and their addition salts with acids
GB8319184D0 (en) Carboxylic acids
IL72227A0 (en) 2-pentanoylaminoacetic acid and salts thereof
PH24099A (en) Solutions of lactic acid salts of piperazinyl-quinolone and piperazinyl-azaquinolone-carboxylic acids
GB8412495D0 (en) Aryloxybenzoic acids
BG35661A1 (en) Method for preparing ureido- beta- lactamic acids and their salts
BG35662A1 (en) Method for preparing ureido- beta- lactamic acids and their salts
IE852940L (en) Salts of 1-phenylimidazole -5-carboxylic acids
GB8320358D0 (en) Preparation of carboxylic acids
PL244565A1 (en) Process for preparing derivetives of azepine-/1,2-a/-pyrimidine and its addition salts with acids
PH20301A (en) Bis-alkylphosphonium salts of n-phosphonomethylglycine